Table 5.
Groups |
Body Weight in g |
|||
---|---|---|---|---|
Initial | 1st Week | 2nd Week | 3rd Week | |
NOC | 30.00 ± 1.41 | 31.10 ± 1.46 | 32.00 ± 1.21 | 32.87 ± 1.12 |
NC | 29.20 ± 1.46 | 26.10 ± 1.63 | 22.82 ± 1.08Ac | 19.6 ± 1.28 Ac |
GL5 | 29.70 ± 1.47 | 28.60 ± 1.48 | 28.10 ± 1.50 | 28.00 ± 1.58Bc |
RELE100 | 29.18 ± 1.58 | 27.40 ± 1.28 | 26.52 ± 1.29Aa | 26.04 ± 1.42 BaAa |
RELE200 | 29.7 ± 0.99 | 28.32 ± 0.98 | 27.28 ± 1.31 | 27.2 ± 1.27 BaAa |
RELE400 | 27.80 ± 0.86 | 26.40 ± 0.83 | 26.00 ± 0.83Aa | 25.9 ± 0.71 BaAa |
Note: Each value represents mean ± S.E.M; n = 6; Analysis was performed by one way ANOVA; acompared to normal control; bcompared to negative control; number followed by RELE and GL indicates dose in mg/kg; ap < 0.05; bp < 0.001.
Abbreviations: NOC, normal control; NC, negative control; GL, glibenclamide; RELE, Rubus erlangeri leaf extract.